James Brumley

James Brumley

James Brumley is a reformed stock broker and former Director of Research for an options-focused newsletter. He’s now primarily a freelance writer, tapping more than a decade’s worth of broad experience to help investors get more out of the market.

With a background in technical analysis as well as fundamental analysis, James writes with a multifaceted philosophy that combines the importance of company performance with the power of stock-trade timing. His commentary is as apt to focus on a chart as it is earnings, as he believes this dual approach is the only way an investor has a shot at consistently beating the market.

James’ work has appeared at several websites, including Street Authority, Motley Fool, Kapitall and Investopedia. When not writing as a journalist, James works on his book explaining his multipronged approach to investing.

Recent Articles

Is Apple Inc. (AAPL) Stock Setting Up a “Sell the News” Scenario?

Apple continues to be the world's most successful company, but that doesn't make AAPL stock impervious to the typical trading mindset.

Why Expedia Inc (EXPE), Sprouts Farmers Market Inc (SFM) and Anadarko Petroleum Corporation (APC) Are 3 of Today’s Worst Stocks

Expedia (EXPE), Sprouts Farmers Market (SFM) and Anadarko Petroleum (APC) shareholders should have made it a three-day weekend.

How Walmart (WMT) Can Hurt Amazon (AMZN) Stock

It's not a reason to dump your Amazon stock, but owners of AMZN stock may want to digest this reality check.

9 Under-the-Radar Retirement Stocks to Buy

Not all retirement stocks have to be household names. Here are some surprisingly-high quality picks even your grandmother could live with.

Why Ulta Beauty Inc (ULTA), Valeant Pharmaceuticals Intl Inc (VRX) and GameStop Corp. (GME) Are 3 of Today’s Worst Stocks

Valeant Pharmaceuticals (VRX), Ulta Beauty (ULTA) and GameStop (GME) shareholders won't be starting the weekend in a great mood.